logo
Plus   Neg
Share
Email

Cummins Slashes FY19 Outlook - Quick Facts

While reporting financial results for the third quarter on Tuesday, Cummins Inc. (CMI) slashed its revenue growth and EBITDA guidance for the full-year 2019.

For fiscal 2019, the company now projects revenues to decline 2 percent, lower than previous guidance of flat with last year.

The company said the reduction in revenue forecast is driven by lower truck production in North America, India, Brazil, and Europe, as well as lower demand in off-highway markets, including North America construction and global mining markets.

Full year EBITDA is also now expected to be 15.9 to 16.3 percent of sales, compared to prior guidance of 16.25 to 16.75 percent, due to the impact of lower volumes and the acquisition of Hydrogenics.

The company noted that the outlook does not include any potential impact of the company's review of its emission certification process and compliance with emissions standards or expenses associated with executing future cost reduction initiatives.

"Cummins is taking actions to align our cost structure with the lower revenues while maintaining investment in products that will deliver sustainable growth and profitability," said Chairman and CEO Tom Linebarger.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Berkshire Hathaway Inc. (BRK.A, BRK.B) announced Wednesday that its CEO billionaire Warren Buffett contributed about 15.97 million "B" shares of Berkshire, valued at about $2.9 billion, to five philanthropies on Tuesday. The shares were given to the following foundations: Bill and Melinda Gates Foundation,... India-based Lupin Pharmaceuticals Inc. announced a recall of all batches of type 2 diabetes medication Metformin Hydrochloride Extended-Release Tablets, citing detection of N-Nitrosodimethylamine or NDMA, a probable human carcinogen. The move comes after many other drug companies called back Metformin tablets after the U.S. Food and Drug Administration or FDA recommended over NDMA concerns. Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, said that the current state of the COVID-19 pandemic in the U.S. is "really not good." The U.S. is the country worst-affected by the coronavirus and has recently seen a surge in coronavirus infections as lockdown restrictions are eased.
Follow RTT